Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1997-12-18
2000-04-11
Peselev, Elli
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
A61K 3170, C07H 1500
Patent
active
060488425
ABSTRACT:
A propiophenone derivative of the formula (I): ##STR1## wherein OX is a hydroxy group which may optionally be protected, Y is a lower alkyl group, and Z is a .beta.-D-glucopyranosyl group wherein one or more hydroxy groups may optionally be protected, or a pharmaceutically acceptable salt thereof. Said compounds have excellent hypoglycemic activity so that they are useful in the prophylaxis or treatment of diabetes.
REFERENCES:
patent: 3984394 (1976-10-01), Westall et al.
patent: 4031260 (1977-06-01), Westall et al.
patent: 4665058 (1987-05-01), Diedrich et al.
patent: 4684627 (1987-08-01), LeVeen et al.
patent: 4760135 (1988-07-01), Diedrich et al.
patent: 4840939 (1989-06-01), Leveen et al.
patent: 5110801 (1992-05-01), Leveen et al.
Textbook of Diabetes, 2.sup.nd Ed., vol. 2, chap. 83.8-83.13 (1997).
The New England Journal of Medicine, vol. 331, pp. 1118-1193 (1994).
The Journal of Pharmacology and Experimental Therapeutics, vol. 275, pp. 194-199 (1995).
Biochim Biophys. Acta, 71, 668, "The Comparative Effects of Some Phlorizin Analogs on the Renal Reabsorption of Glucose", pp. 688-700, 1963.
Diabetes Cares, vol. 13, No. 6, "Glucose Toxicity", pp. 610-630, 1990.
J. Clin. Invest., vol. 79, Correction of Hyperglycemia with Phlorizin Normalizes Tissue Sensitivity to Insulin in Diabetic Rats, pp. 1510-1515, 1987.
J. Clin. Invest., vol. 80, "Effect of Chronic Hyperglycemia on In Vivo Insulin Secretion in Partially Pancreatectomized Rats", pp. 1037-1044, 1987.
J. Clin. Invest., vol. 87, "Normalization of Blood Glucose in Diabetic Rats with Phlorizin Treatment Reverses Insulin-resistant Glucose Transport in Adipose Cells without Restoring Glucose Transporter Gene Expression", pp. 561-570, 1991.
Diabetologia, vol. 28, "Hyperglycaemia as an inducer as well as a consequence of impaired isle cell function and insulin resistance: implications for the management of diabetes", pp. 119-121, 1985.
Stroke, vol. 14, "Rapid, Transient Drop in Brain Glucose After Intravenous Phloretin or 3-0-Methyl-D-Glucose", pp. 388-393, 1983.
Biochemistry, vol. 8, No. 5, "The Inhibition of Photophosphorylation by Phlorizin and Closely Related Compounds", pp. 2067-2073, 1969.
American Journal of Physiology, vol. 224, No. 3, "Reevaluation of renal tubular glucose transport inhibition by phlorizin analogs", pp. 552-557, 1973.
Archives of Biochemistry and Biophysics, vol. 117, "Competitive Inhibition of Intestinal Glucose Transport by Phlorizin Analogs", pp. 248-256, 1966.
Archives of Biochemistry and Biophysics, vol. 199, No. 2, "The Affinity of Phlorizin-Like Compounds for a .beta.-Glucosidase in Intestin Brush Borders: Comparison with Glucose Transport System", pp. 342-348, 1980.
Biochim. Biophys. Acta, 290, "Inhibition of [.sup.3 H] Phlorizin Binding to Isolated Kidney Brush Border Membranes by Phlorizin-Like Compounds", pp. 134-149, 1972.
J. Nutr. Sci. Vitaminol, 38 (1) pp. 27-37, ISSN 0301-4800, Tokyo, Japan, Feb. 1992.
Diabetes, vol. 37, "Characterization of New Oral Antidiabetic Agent CS-045", pp. 1549-1558, 1988.
Acta Alimentaria, vol. 11 (1), "Effect of a Synthetic Dihydrochalcone Sweetener (Chinoin-401) on Carbohydrate Metabolism", pp. 31-37, 1982.
Hongu Mitsuya
Matsumoto Mamoru
Oku Akira
Saito Kunio
Tsujihara Kenji
Peselev Elli
Tanabe Seiyaku Co. Ltd.
LandOfFree
Propiophenone derivatives and process for preparing the same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Propiophenone derivatives and process for preparing the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Propiophenone derivatives and process for preparing the same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1176656